Archives
CDC Guidance: Preparing Long-term Care Facilities and Nursing Homes for COVID-19
24 Mar, 2020 | 11:28h | UTCRelated Guideline: Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF)
Related Article: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report
Related Perspective: The Coronavirus’s Rampage Through a Suburban Nursing – The New York Times
COVID-19: Updates for Gastroenterologists
25 May, 2020 | 00:01h | UTCGuidelines:
- AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 – American Gastroenterology Association
- Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic – Singapore Medical Journal (05/2020)
- Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19 – Journal of Clinical and Experimental Hepatology (05/2020)
- COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response – National Institute for Health and Care Excellence (05/2020)
- Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance – Clinics (04/2020)
- AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary – Gastroenterology (04/2020)
- Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting – Gastroenterology (04/2020)
- Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper – JHEP Reports (04/2020)
- Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement – Hepatology (04/2020)
- Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID Position Paper – European Association for the Study of the Liver (EASL) AND News Release: Patients with advanced liver disease and transplant recipients require specific care during COVID-19 – European Association for the Study of the Liver (EASL) (04/2020)
- AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic – American Gastroenterological Association AND News Release: AGA issues formal recommendations for PPE during gastrointestinal procedures (04/2020)
- Coronavirus (COVID-19) outbreak: what the department of endoscopy should know – Gastrointestinal Endoscopy AND Commentary: Endoscopy During the COVID-19 Pandemic – NEJM Journal Watch (03/2020)
Selected Articles:
- NEW – Liver Biochemistries in Hospitalized Patients With COVID‐19 – Hepatology (05/2020)
- NEW – Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children – The Lanced Child & Adolescent Health (05/2020)
- NEW – Prevention of nosocomial SARS-CoV-2 transmission in endoscopy: international recommendations and the need for a gold standard – Gut (05/2020)
- Abdominal Imaging Findings in COVID-19: Preliminary Observations – Radiology AND News Release: Imaging reveals bowel abnormalities in patients with COVID-19 – Radiological Society of North America (05/2020)
- COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation – Clinical Gastroenterology and Hepatology (05/2020)
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis – The Lancet Gastroenterology & Hepatology (05/2020)
- Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19 – Journal of Clinical Virology (05/2020)
- Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies – Hepatology Research (05/2020)
- Practical Advice for Management of IBD Patients during the COVID‐19 Pandemic: A World Endoscopy Organization Statement – Digestive Endoscopy (05/2020)
- Patient Page: What to Know About Liver Disease and COVID-19 – Centers for Disease Control and Prevention (05/2020)
- Longitudinal association between markers of liver injury and mortality in COVID‐19 in China – Hepatology (05/2020)
- SARS-CoV-2 productively infects human gut enterocytes – Science AND Commentaries: SARS-CoV-2 Infection of Gut Organoids Bolsters Case for Intestinal Transmission – GEN AND Coronavirus SARS-CoV-2 infects cells of the intestine – Hubrecht Institute (05/2020)
- Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study – Gastroenterology (05/2020)
- Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis – Cureus (05/2020)
- Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review – Gastroenterology (05/2020)
- Review Article: Prevention, Diagnosis and Management of COVID‐19 in the Inflammatory Bowel Disease Patient – Alimentary Pharmacology and Therapeutics (05/2020)
- Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health – International Journal of Infectious Diseases (05/2020)
- Low risk of covid-19 transmission in GI endoscopy – Gut (04/2020)
- Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 – Clinical Gastroenterology and Hepatology (04/2020)
- Characteristics of Liver Tests in COVID-19 Patients – Journal of Hepatology (04/2020)
- Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID‑19): a pooled analysis – Internal and Emergency Medicine (04/2020)
- A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs – Clinical Microbiology and Infection (04/2020)
- Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States – Gastroenterology (04/2020)
- COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy – The Lancet Gastroenterology & Hepatology AND Commentary: Liver Transplant: If No COVID-19 Symptoms, Immunosuppressants OK – MedPage Today (free registration required) (04/2020)
- COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies – Digestive Endoscopy (04/2020)
- Clinical Features of COVID-19-Related Liver Damage – Clinical Gastroenterology and Hepatology (04/2020)
- Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 – Journal of Microbiology, Immunology and Infection (04/2020)
- Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management – Clinical Gastroenterology and Hepatology (04/2020)
- COVID-19 and liver disease – Liver International (04/2020)
- [Preprint] Liver injury is associated with severe Coronavirus disease 2019 (COVID‑19) infection: a systematic review and meta-analysis of retrospective studies – medRxiv (04/2020)
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis – Gastroenterology AND Commentary: Gastrointestinal Aspects of COVID-19 – NEJM Journal Watch (04/2020)
- Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective – Journal of Digestive Diseases (04/2020)
- Pancreatic injury patterns in patients with COVID-19 pneumonia – Gastroenterology (04/2020)
- COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies – Journal of Clinical and Translational Hepatology (04/2020)
- Digestive Symptoms in COVID-19 Patients with Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes – American Journal of Gastroenterology (04/2020)
- Covid‐19 and the Digestive System – Journal of Gastroenterology and Hepatology (03/2020)
- COVID-19: faecal–oral transmission? – Nature Gastroenterology and Hepatology (03/2020)
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms – Gut (03/2020)
- COVID-19 in gastroenterology: a clinical perspective – Gut
- Autopsy in suspected COVID-19 cases – Journal of Clinical Pathology (03/2020)
- COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020 – Journal of the Canadian Association of Gastroenterology (03/2020)
- Prolonged presence of SARS-CoV-2 viral RNA in faecal samples – The Lancet Gastroenterology & Hepatology (03/2020)
- COVID-19 and the liver: little cause for concern – The Lancet Gastroenterology & Hepatology (03/2020)
- Don’t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) – Clinical Gastroenterology and Hepatology (03/2020)
- What Should Gastroenterologists and Patients Know About COVID-19? – Clinical Gastroenterology and Hepatology (03/2020)
- Effect of gastrointestinal symptoms on patients infected with COVID-19 – Gastroenterology (03/2020)
- Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study – American Journal of Gastroenterology AND Commentaries: Study from The American Journal of Gastroenterology Reveals Diarrhea is a Prominent Symptom of COVID-19 – American College of Gastroenterology AND Diarrhea a key symptom in 1 of 4 COVID-19 patients, study finds – UPI (03/2020)
- Liver injury during highly pathogenic human coronavirus infections – Liver International (03/2020)
- Implications of COVID-19 for patients with pre-existing digestive diseases – The Lancet Gastroenterology & Hepatology (03/2020)
- COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission – Gastroenterology (03/2020)
- Evidence for gastrointestinal infection of SARS-CoV-2 – Gastroenterology AND Commentary: Gastrointestinal manifestations and fecal-oral transmission of novel coronavirus – New Medical (03/2020)
COVID-19 Gastroenterology: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
COVID-19: Updates for Oncologists & Hematologists
25 May, 2020 | 00:01h | UTCOncology Guidelines
- Cancer Patient Management During the Covid-19 Pandemic – European Society of Medical Oncology
- Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic – Otolaryngology–Head and Neck Surgery (05/2020)
- Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk – JCO Oncology Practice (05/2020)
- Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report – Journal of the American College of Radiology (05/2020)
- A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises – Radiotherapy and Oncology (05/2020)
Oncology Articles
- Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic – The Lancet Oncology (05/2020)
- Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations – Annals of Surgical Oncology (05/2020)
- To Do or Not to Do?—A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic – Indian Journal of Surgical Oncology (05/2020)
- COVID-19 and Cancer: a Comprehensive Review – Current Oncology Reports (05/2020)
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARSCoV-2: a population-based study (n=4532) – Annals of Oncology (05/2020)
- Palliative Care for Patients With Cancer in the COVID-19 Era – JAMA Oncology (05/2020)
- Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan – The Lancet Oncology (05/2020)
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence – Critical Reviews in Oncology/Hematology (05/2020)
- Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases – Leukemia (05/2020)
- Bracing for impact with new 4R’s in the COVID-19 pandemic- a provincial thoracic radiation oncology consensus – Radiotherapy and Oncology (05/2020)
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak – Cancer Discovery AND Commentaries: COVID-19 Increases Overall Risk of Death, Complications in Patients With Cancer, Study Shows – AJMC AND Patients with blood and lung cancers are three times more at risk of dying of coronavirus than people with other tumors, study finds – Daily Mail AND Coronavirus: Cancer patients nearly three times more likely to die of Covid-19, study says – Independent (05/2020)
- Cancer Management in India during Covid-19 – New England Journal of Medicine (05/2020)
- COVID-19 in persons with haematological cancers – Leukemia (05/2020)
Hematologic Guidelines
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 – Journal of the American College of Cardiology
- Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID‐19 pandemic – British Journal of Haematology (05/2020)
- Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands – Radiology (05/2020)
- Patient blood management during the COVID‐19 pandemic ‐ a narrative review – Anaesthesia (05/2020)
Hematology Articles
- NEW – Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum – Journal of Thrombosis and Thrombolysis (05/2020)
- NEW – Thromboprophylaxis for medical inpatients with COVID-19 – Clinical Microbiology and Infection (05/2020)
- NEW – COVID-19 and coagulative axis: review of emerging aspects in a novel disease – Monaldi Archives for Chest Disease (05/2020)
- Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet (05/2020)
- Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 – Intensive Care Medicine (05/2020)
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine (05/2020)
- Care of Patients with Hemoglobin Disorders during the COVID-19 Pandemic: An Overview of Recommendations – American Journal of Hematology (05/2020)
- COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review – Critical Care (05/2020)
- Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis – International Journal of Infectious Diseases (05/2020)
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study – Intensive Care Medicine (05/2020)
- Coronavirus blood-clot mystery intensifies – Nature (05/2020)
- Arterial thromboembolic complications in COVID‐19 in low risk patients despite prophylaxis – British Journal of Haematology (05/2020)
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study – Annal of Internal Medicine (05/2020)
- Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 – The Lancet (05/2020)
- Coagulopathy associated with COVID-19 – Canadian Medical Association Journal (05/2020)
- Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge – Thrombosis and Haemostasis (05/2020)
- Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? – Thrombosis and Haemostasis (05/2020)
- The resurgence of convalescent plasma therapy – The Lancet Haematology (05/2020)
- COVID-19 and its implications for thrombosis and anticoagulation – Blood (05/2020)
Guidelines:
- Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis (04/2020)
- Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID19 Pandemic – American Society of Medical Oncology AND Commentary: ASCO Releases New Guidance on Allocation of Limited Resources in the Oncology Community During COVID-19 Pandemic – The ASCO Post (04/2020)
- Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 – Thrombosis UK (04/2020)
- ISTH interim guidance on recognition and management of coagulopathy – Journal of Thrombosis and Haemostasis (04/2020)
- Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe – Journal of the National Comprehensive Cancer Network AND News Release: JNCCN: Improving COVID-19 safety for cancer patients and healthcare providers – National Comprehensive Cancer Network (04/2020)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement – Radiotherapy and Oncology (04/2020)
- Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic – FRANCOGYN group for the CNGOF – Journal of Gynecology Obstetrics and Human Reproduction (04/2020)
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group – The Oncologist (04/2020)
- COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence (03/2020)
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network (03/2020)
Articles:
- COVID‐19 Infection in Patients with Sickle Cell Disease – British Journal of Haematology (04/2020)
- COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis – JCO Global Oncology AND Commentaries: Meta-analysis highlights COVID-19 risk in cancer patients, survivors – Medicine Matters (04/2020)
- Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology (04/2020)
- COVID-19: impact on cancer workforce and delivery of care – The Lancet Oncology (04/2020)
- Caring for our cancer patients in the wake of COVID-19 – British Journal of Cancer (04/2020)
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 – Journal of Thrombosis and Haemostasis (04/2020)
- Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19 – Journal of Thrombosis and Haemostasis (04/2020)
- Caring for patients with cancer in the COVID-19 era – Nature Medicine AND Commentary: Caring for cancer patients in the COVID-19 era – Netherlands Cancer Institute (04/2020)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up – Journal of the American College of Cardiology AND Commentary: JACC Paper Outlines Implications, Considerations For Thrombotic Disease Patients During COVID-19 Pandemic – American College of Cardiology (04/2020)
- The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer – JACC CardioOncology (04/2020)
- Hematological findings and complications of COVID‐19 – American Journal of Hematology (04/2020)
- COVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology (04/2020)
- Immune Thrombocytopenic Purpura in a Patient with Covid-19 – New England Journal of Medicine (04/2020)
- Oncology Practice During the COVID-19 Pandemic – JAMA (04/2020)
- D-dimer cutoffs to predict thrombosis in COVID-19 – PulmCrit (04/2020)
- Caring for Patients With Cancer During the COVID-19 Outbreak in Italy – JAMA Oncology (04/2020)
- Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic – Journal of Visceral Surgery (04/2020)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments – Radiation Oncology (04/2020)
- Testing the association between blood type and COVID-19 infection, intubation, and death – medRxiv (04/2020)
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 – New England Journal of Medicine (04/2020)
- How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere – ESMO Open (04/2020)
- Cancer guidelines during the COVID-19 pandemic – The Lancet Oncology (04/2020)
- D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis – Thrombosis and Haemostasis (04/2020)
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy – Journal of Thrombosis and Haemostasis (04/2020)
- Q & A: COVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology (04/2020)
- Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China – Annals of Oncology (04/2020)
- A War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine (03/2020)
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta (03/2020)
- Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia – Journal of Thrombosis and Haemostasia
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China – JAMA Oncology AND Commentary: Cancer linked to increased COVID-19 risk – MedwireNews (03/2020)
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China – The Lancet Oncology AND Commentaries: Risk of COVID-19 for patients with cancer – The Lancet Oncology AND Risk of COVID-19 for cancer patients – The Lancet Oncology (03/2020)
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection – Clinical Chemistry and Laboratory Medicine (03/2020)
- Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection – Pediatric Blood & Cancer (03/2020)
- Risk of COVID-19 for patients with cancer – The Lancet Oncology (03/2020)
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis – Clinica Chimica Acta
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network (03/2020)
- How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat? – British Journal of Haematology (03/2020)
News & Perspectives:
- The Blind Leading the Blind: COVID-19, Cancer, and the Need for More Data – ASCO Daily News (03/2020)
- Mitigating the Spread of COVID-19 and Its Impact on Cancer: How Cancer Centers Are Preparing for the Coronavirus – The ASCO Post (03/2020)
- The Treatment of Patients With Cancer and Containment of COVID-19: Experiences From Italy – ASCO Daily News (03/2020)
- Coronavirus means difficult, life-changing decisions for me and my cancer patients – The Guardian (03/2020)
COVID-19 Hemato-Oncology: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
COVID-19: Updates for Cardiologists
25 May, 2020 | 00:01h | UTCPodcasts:
- Practice Made Perfect: What You Need to Know Now About Managing Individuals With COVID-19 – American College of Cardiology (04/2020)
- Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality – JAMA Cardiology (03/2020)
Guidelines:
- Current perspectives on Coronavirus 2019 (COVID‐19) and cardiovascular disease: A white paper by the JAHA editors – Journal of the American Heart Association
- Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies
- EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic – European Heart Journal (05/2020)
- COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence (04/2020)
- ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology (04/2020)
- Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS Physicians – Circulation AND News Release: Interim CPR guidelines address challenges of providing resuscitation during COVID-19 pandemic – American Heart Association (04/2020)
- Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment – Circulation AND News Release: Caution recommended on COVID-19 treatment with hydroxychloroquine and azithromycin for patients with cardiovascular disease – American Heart Association AND Commentaries: Medical groups urge caution when using hydroxychloroquine, azithromycin to treat COVID-19 patients with CVD – Cardiovascular Business AND AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients – DAIC (04/2020)
- Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement – JACC: Cardiovascular Interventions AND Commentary: ACC/SCAI Consensus Document Guides Triage For Structural Heart Disease During COVID-19 Pandemic (04/2020)
- COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel – European Heart Journal – Cardiovascular Imaging (04/2020)
- Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association – Heart Rhythm (04/2020)
- CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic – Circulation (03/2020)
- Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak – European Heart Journal (04/2020)
- Resuscitation Council UK Statements on COVID-19 (Coronavirus), CPR and Resuscitation (03/2020)
- Society of Cardiovascular Computed Tomography Guidance for Use of Cardiac Computed Tomography Amidst the COVID-19 Pandemic – Journal of Cardiovascular Computed Tomography AND Commentary: ACC Endorses Clinical Guidance on Cardiovascular CT – American College of Cardiology (03/2020)
- General Guidance on Deferring Non-Urgent CV Testing and Procedures During the COVID-19 Pandemic – American College of Cardiology (03/2020)
- Interim Guidance for Healthcare Providers during COVID-19 Outbreak – American Heart Association AND News Release: Interim guidance to reduce COVID-19 transmission during resuscitation care – American Heart Association (03/2020)
- Troponin and BNP Use in COVID-19 – Cardiology Magazine, American College of Cardiology (03/2020)
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic – Journal of the American College of Cardiology AND Commentary: CVD in the Setting of COVID-19: Considerations to Prepare Patients, Providers, Health Systems – American College of Cardiology (03/2020)
- HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND Commentaries: Patients with COVID-19 should keep taking key CVD medications – Cardiovascular Business AND Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician – American Heart Association (03/2020)
- The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use (03/2020)
- Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology (03/2020)
Selected Articles:
- NEW – Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic – Journal of Cardiac Failure (05/2020)
- NEW – Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy – European Heart Journal AND Commentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology (05/2020)
- NEW – Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19) – Journal of Cardiovascular Pharmacology (05/2020)
- NEW – The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction – New England Journal of Medicine (05/2020)
- NEW – ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis – Pharmacological Research (05/2020)
- Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit – JAMA Cardiology
- Editorial: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 – New England Journal of Medicine
- Study 1: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 – New England Journal of Medicine
- Study 2: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 – New England Journal of Medicine
- Study 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine
- Study 4: Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study – Hypertension
- Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era – Diabetes Care (05/2020)
- QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin – Heart Rhythm (05/2020)
- Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 – European Heart Journal (05/2020)
- Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management – Heart Rhythm (05/2020)
- Challenges For the Cardiovascular Community During the COVID-19 Pandemic – ACC Cardiology Magazine (05/2020)
- Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician – Circulation (05/2020)
- Multivessel coronary thrombosis in a patient with COVID-19 pneumonia – European Heart Journal (05/2020)
- [Preprint] Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis – medRxiv (05/2020)
- Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty – Current Cardiology Reports (05/2020)
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) – JAMA Cardiology (05/2020)
- Cardiac considerations in patients with COVID-19 – Canadian Medical Association Journal (05/2020)
- Cardiovascular manifestations and treatment considerations in covid-19 – Heart (05/2020)
- COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options – Cardiovascular Research (05/2020)
- Hypertension is a clinically important risk factor for severe illness and mortality in COVID‐19 – Anaesthesia (05/2020)
- Understanding the Renin-Angiotensin Aldosterone-SARS-CoV-Axis: A Comprehensive Review – European Respiratory Review (05/2020)
- Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine (05/2020)
- Renin–angiotensin–aldosterone system inhibitors and COVID-19 – Canadian Medical Association Journal (05/2020)
- Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis – American Journal of Emergency Medicine (05/2020)
- Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes – The Lancet (04/2020)
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China – JAMA Cardiology AND Commentary: Drugs for high blood pressure don’t appear to make COVID-19 worse – Science News (04/2020)
- Cardiovascular complications in COVID-19 – American Journal of Emergency Medicine (04/2020)
- Clare Taylor: For people with heart failure, covid-19 presents a challenge – The BMJ Opinion (04/2020)
- Cardio-oncology Care in the Time of COVID-19 and the Role of Telehealth – JACC: CardioOncology (04/2020)
- Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms – Journal of Cardiac Failure (04/2020)
- The Obstacle Course of Reperfusion for STEMI in the COVID-19 Pandemics – Circulation (04/2020)
- Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic – Circulation (04/2020)
- Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger? – Science (04/2020)
- Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology (04/2020)
- Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome – Circulation (04/2020)
- ST-Segment Elevation in Patients with Covid-19 — A Case Series – New England Journal of Medicine (04/2020)
- The Science Underlying COVID-19: Implications for the Cardiovascular System – Circulation (04/2020)
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up – Journal of the American College of Cardiology AND Commentary: JACC Paper Outlines Implications, Considerations For Thrombotic Disease Patients During COVID-19 Pandemic – American College of Cardiology (04/2020)
- Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy – European Heart Journal AND Commentaries: Priorities for Cath Labs in the COVID-19 Tsunami – American College of Cardiology (04/2020)
- Related: Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation AND As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI – TCTMD (04/2020)
- Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective – Journal of the American College of Cardiology (04/2020)
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 – Circulation Research (04/2020)
- COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations – Circulation AND Commentary: COVID-19 and Renin Angiotensin Blockers – American (04/2020)
- Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings – Circulation (04/2020)
- The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments – European Journal of Epidemiology (04/2020)
- Management of the Hospitalized COVID-19 Patient With Acute Cardiomyopathy or Heart Failure – American College of Cardiology (04/2020)
- The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer – JACC CardioOncology (04/2020)
- Covid-19 and hypertension: risks and management – The BMJ Opinion (04/2020)
- End-stage Heart Failure with COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV – JACC: Heart Failure (04/2020)
- Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic – Journal of the American College of Cardiology (04/2020)
- COVID-19-related myocarditis in a 21-year-old female patient – European Heart Journal (04/2020)
- Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) – Journal of Cardiovascular Pharmacology (04/2020)
- COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! – Circulation (04/2020)
- Perspective: cardiovascular disease and the Covid-19 pandemic – Basic Research in Cardiology (04/2020)
- Reperfusion of STEMI in the COVID-19 Era – Business as Usual? – Circulation (04/2020)
- First case of COVID-19 complicated with fulminant myocarditis: a case report and insights – Infection (04/2020)
- Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society – Indian Pacing and Electrophysiology Journal (04/2020)
- Editorial: Cardiopulmonary Resuscitation after Hospital Admission with Covid-19 – The BMJ (04/2020)
“This pandemic has changed the risk-benefit balance for CPR: from “there is no harm in trying” to “there is little benefit to the patient, and potentially significant harm to staff.””
- Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China – JAMA Network Open AND Commentary: New Wuhan Data Confirm High Hypertension Rate in COVID-19 Deaths – TCTMD (04/2020)
- In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China – Resuscitation (04/2020)
- Recommendations on cardiopulmonary resuscitation strategy and procedure for novel coronavirus pneumonia – Resuscitation (04/2020)
- COVID-19 and the Heart – Circulation Research (04/2020)
- The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease – International Journal of Cardiology (04/2020)
- Myocardial localization of coronavirus in COVID‐19 cardiogenic shock – European Journal of Heart Failure (04/2020)
- Palliative Care Considerations For Patients With Cardiovascular Disease Under COVID-19 – American College of Cardiology (04/2020)
- Cardiac and arrhythmic complications in Covid‐19 patients – Journal of Cardiovascular Electrophysiology (04/2020)
- [Preprint] Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study – medRxiv (04/2020)
- [Preprint] Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust – medRxiv (04/2020)
- ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties – Mayo Clinic Proceedings AND News Release: Mayo Clinic experts offer guidance on treating COVID-19 patients with signs of acute heart attack – Mayo Clinic (04/2020)
- Complete Guide to CARDIAC Ultrasound in COVID-19 (Coronavirus) – POCUS 101 (04/2020)
- Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 – Mayo Clinic Proceedings (04/2020)
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19 – Mayo Clinic Proceedings (04/2020)
- Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection – European Heart Journal (04/2020)
- Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 – Mayo Clinic Proceedings (04/2020)
- Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients – eLife (04/2020)
- Cardiovascular disease and COVID-19 – Diabetes & Metabolic Syndrome: Clinical Research & Reviews (04/2020)
- Coronavirus Disease 2019 (COVID-19): Epidemiology, Clinical Spectrum and Implications for the Cardiovascular Clinician – American College of Cardiology (04/2020)
- Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers – JAMA Cardiology (04/2020)
- The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science – JAMA Cardiology (04/2020)
- Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic – Nature Reviews Nephrology (04/2020)
- The Variety of Cardiovascular Presentations of COVID-19 – Circulation (04/2020)
- Angiotensin-Converting Enzyme 2 and Anti-Hypertensives (Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors) in Coronavirus Disease 2019 (COVID-19) – Mayo Clinic Proceedings AND Commentary: Blood Pressure Meds ACEIS and ARBS and Covid-19 Infection – MedicalResearch.com (04/2020)
- Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19 – American College of Cardiology (03/2020)
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 – New England Journal of Medicine (03/2020)
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China – JAMA Cardiology AND Commentaries: Cardiac injury linked to increased mortality in COVID-19 – MedicalXpress AND Cardiac injury in COVID-19 patients associated with higher in-hospital mortality – Cardiovascular Business AND Cardiac Injury and Mortality in Hospitalized COVID-19 Patients – American College of Cardiology (03/2020)
- Viewpoint: An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases – JAMA Cardiology (03/2020)
- COVID-19 Illness and Heart Failure: A Missing Link? – JACC: Heart Failure (03/2020)
- COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? – JAMA (03/2020)
- Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis – Progress in Cardiovascular Diseases AND Commentary: Meta-Analysis on Troponin I in Patients With Coronavirus – Latest in Cardiology (03/2020)
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China – Circulation: Cardiovascular Quality and Outcomes (03/2020)
- Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin – European Heart Journal (03/2020)
- How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital – Intensive Care Medicine (03/2020)
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? – The Lancet Respiratory Medicine (03/2020)
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China – Clinical Research in Cardiology (03/2020)
- How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital – Intensive Care Medicine (free)
- Potential Effects of Coronaviruses on the Cardiovascular System: A Review – JAMA Cardiology AND Editorial: Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality (03/2020)
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers – Hypertension AND Commentary: COVID-19 alert: Heart and kidney patients should keep taking their medicines – University of Miami Miller School of Medicine (03/2020)
- Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease – Circulation (03/2020)
- COVID-19 and the cardiovascular system – Nature Reviews Cardiology (03/2020)
- Cardiologists and Coronavirus: Looking after ourselves and each other so we can continue to look after patients – Heart (03/2020)
- Coronaviruses and the cardiovascular system: acute and long-term implications – European Heart Journal (03/2020)
- SARS-CoV-2: a potential novel etiology of fulminant myocarditis – Herz (03/2020)
COVID-19 Cardiology: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
COVID-19 Updates for Obstetricians
18 May, 2020 | 00:30h | UTCPodcasts:
- The Lancet Voice: Pregnancy and COVID-19 (03/2020)
Guidelines:
- ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals – an update – International Society of Ultrasound in Obstetrics and Gynecology (05/2020)
- Care for Breastfeeding Women – Centers for Disease Control and Prevention (05/2020)
- General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic – American Journal of Perinatology (05/2020)
- ISIDOG Recommendations Concerning COVID-19 and Pregnancy – Diagnostics (05/2020)
- Novel Coronavirus 2019 (COVID-19) – American College of Obstetricians and Gynecologists AND FAQs: COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics – American College of Obstetricians and Gynecologists AND Algorithm: Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) AND Commentary: COVID-19 Obstetric Practice Recommendations from ACOG – NEJM Journal Watch (04/2020)
- Operating Room Guide for Confirmed or Suspected COVID-19 Pregnant Patients Requiring Cesarean Delivery – American Journal of Perinatology (04/2020)
- Global interim guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals – International Journal of Gynecology & Obstetrics (04/2020)
- Updated SOGC Committee Opinion – COVID-19 in Pregnancy – Society of Obstetricians and Gynaecologists of Canada (03/2020)
- Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection – Gynecology & Obstetrics (03/2020)
- Coronavirus (COVID-19) infection and pregnancy – Royal College of Obstetricians & Gynaecologists AND News Release: National guidance on managing coronavirus infection in pregnancy published (03/2020)
- ABM Statement on Coronavirus 2019 (COVID-19) – Academy of Breastfeeding Medicine (03/2020)
- ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals (03/2020)
Articles:
- NEW – Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations – Journal of Gynecology Obstetrics and Human Reproduction (05/2020)
- NEW – COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies – Cochrane Pregnancy and Childbirth (05/2020)
- Guideline Summary: Coronavirus (COVID-19) Infection in pregnancy – RCOG / The BMJ (05/2020)
- Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review – The Journal of Maternal-Fetal & Neonatal Medicine (05/2020)
- Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19) – American Journal of Obstetrics and Gynecology (05/2020)
- [Preprint] SARS-CoV-2 Infection of the Placenta – medRxiv (05/2020)
- [Preprint] Effects of Coronavirus Disease 2019 (COVID-19) on Maternal, Perinatal and Neonatal Outcomes: a Systematic Review of 266 Pregnancies – medRxiv (05/2020)
- Early Acute Respiratory Support for Pregnant Patients With Coronavirus Disease 2019 (COVID-19) Infection – Obstetrics & Gynecology (05/2020)
- Severe ARDS in COVID-19-infected pregnancy: obstetric and intensive care considerations – American Journal of Obstetrics & Gynecology MFM (05/2020)
- [Preprint] Pregnancy and breastfeeding during COVID-19 pandemic: A systematic review of published pregnancy cases – medRxiv AND Commentary: Impact of COVID-19 on pregnancy and breastfed infants – News Medical (05/2020)
- Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic – Obstetrics & Gynecology (05/2020)
“We recommend and urge the scientific community and professional societies that, without clear justification for exclusion, pregnant women should be given the opportunity to be included in clinical trials for COVID-19 based on the concepts of justice, equity, autonomy, and informed consent.”
- Coronavirus disease 2019 in pregnancy – International Journal of Infectious Diseases (05/2020)
- Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation – Obstetrics & Gynecology (05/2020)
- Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection – JAMA (05/2020)
- Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases – American Journal of Obstetrics and Gynecology (05/2020)
- Covid-19: The time to shield all pregnant frontline workers is now – The BMJ Opinion (05/2020)
- A systematic scoping review of COVID‐19 during pregnancy and childbirth – International Journal of Obstetrics & Gynecology (05/2020)
- No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy – The Lancet Infectious Diseases (04/2020)
- A call for action for COVID-19 surveillance and research during pregnancy – The Lancet Global Health (04/2020)
- COVID19 during pregnancy: a systematic review of reported cases – American Journal of Obstetrics and Gynecology (04/2020)
- Care of the Pregnant Woman with COVID-19 in Labor and Delivery: Anesthesia, Emergency cesarean delivery, Differential diagnosis in the acutely ill parturient, Care of the newborn, and Protection of the healthcare personnel – American Journal of Obstetrics and Gynecology (04/2020)
- Obstetric Anesthesia During the COVID-19 Pandemic – Anesthesia & Analgesia (04/2020)
- Maternal and Perinatal Outcomes with COVID‐19: a systematic review of 108 pregnancies – Acta Obstetricia et Gynecologica Scandinavica (04/2020)
- Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic – American Journal of Perinatology (04/2020)
- Delivery in pregnant women infected with SARS‐CoV‐2: A fast review – International Journal of Gynecology & Obstetrics (04/2020)
- Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm – Breastfeeding Medicine AND Commentary: Should infants be separated from COVID-19-positive mothers – EurekAlert (04/2020)
- Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection – American Journal of Perinatology (04/2020)
- Safe Delivery for COVID‐19 Infected Pregnancies – Obstetrics & Gynaecology (04/2020)
- Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy – American Journal of Obstetrics and Gynecology (04/2020)
- New coronavirus leaves pregnant women with wrenching choices—but little data to guide them – Science (03/2020)
- Infants Born to Mothers With a New Coronavirus (COVID-19) – Frontiers in Pediatrics AND Commentary: Chinese case study suggests COVID-19 is not transmitted from pregnant mothers to newborns – Frontiers (03/2020)
- Coronavirus in pregnancy and delivery: rapid review – Ultrasound in Obstetrics & Gynecology (03/2020)
Information for Pregnant Women and Their Families:
- Q&A on COVID-19, pregnancy, childbirth and breastfeeding – World Health Organization (03/2020)
- Coronavirus infection and pregnancy – Royal College of Obstetricians and Gynaecologists (03/2020)
COVID-19 Obstetrics: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
COVID-19: Updates for Nephrologists
25 May, 2020 | 00:02h | UTCPodcast:
- NEW – Podcast 267: Acute kidney injury in COVID-19 — how one New York system dealt with it – NEJM Clinical Conversations (05/2020)
Guidelines:
- COVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence (05/2020)
- COVID-19 rapid guideline: acute kidney injury in hospital – National Institute for Health and Care Excellence (05/2020)
- COVID-19 rapid guideline: dialysis service delivery – National Institute for Health and Care Excellence (03/2020)
- Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in dialysis facilities – Centers for Medicare & Medicaid Services (03/2020)
- Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities – Centers for Disease Control and Prevention (03/2020)
- Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres – Nephrology Dialysis Transplantation
- HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND Commentaries: Patients with COVID-19 should keep taking key CVD medications – Cardiovascular Business AND Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician – American Heart Association (03/2020)
- The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use (03/2020)
- Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology (03/2020)
Articles:
- Multiorgan and Renal Tropism of SARS-CoV-2 – New England Journal of Medicine (05/2020)
- Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China – Journal of the American Society of Nephrology (05/2020)
- Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia – Journal of the American Society of Nephrology (05/2020)
- Recommendations for prevention and management of COVID-19 in peritoneal dialysis patients – Chronic Diseases and Translational Medicine (05/2020)
- [Preprint] Acute Kidney Injury in Hospitalized Patients with COVID-19 – medRxiv (05/2020)
- [Preprint] AKI during COVID-19 infection: low incidence, high risk of death – medRxiv (05/2020)
- [Preprint] The Chronic Kidney Disease and Acute Kidney Injury Involvement in COVID-19 Pandemic: A Systematic Review and Meta-analysis – medRxiv (05/2020)
- Peritoneal Dialysis During the Coronavirus 2019 (COVID-19) Pandemic: Acute Inpatient and Maintenance Outpatient Experiences – Kidney Medicine (05/2020)
- Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic – Clinical Journal of the American Society of Nephrology (05/2020)
- Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients – Clinical Journal of the American Society of Nephrology (05/2020)
- Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic – Pediatric Nephrology (05/2020)
- Acute kidney injury in SARS-CoV-2 infected patients – Critical Care
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China – Kidney International (04/2020)
- Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic – Blood Purification (04/2020)
- Kidney disease is associated with in-hospital death of patients with COVID-19 – Kidney International (04/2020)
- COVID-19 and the Inpatient Dialysis Unit – Clinical Journal of the American Society of Nephrology (04/2020)
- On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe – Clinical Journal of the American Society of Nephrology (03/2020)
- CKD and Dialysis in the Time of COVID-19 – NephJC (03/2020)
- ERA-EDTA sharing Milan experience on coronavirus management in dialysis centres – Clinical Kidney Journal
- Mitigating Risk of COVID-19 in Dialysis Facilities – Clinical Journal of the American Society of Nephrology
COVID-19 Nephrology: This page will be updated as often as necessary and will be fixed in the right column on our homepage.
COVID-19: Updates in Bioethics
25 May, 2020 | 00:01h | UTCResource Centers:
- Ethics Resources on the Coronavirus (COVID-19) – The Hastings Center
- COVID-19 Ethics Resource Center – AMA Journal of Ethics
Guidelines:
- AGS Position Statement: Resource Allocation Strategies and Age‐Related Considerations in the COVID‐19 Era and Beyond – Journal of the American Geriatrics Society AND News Release: Position statement addresses difficult issue: allocating scare resources in COVID-19 era – American Geriatrics Society
- Allocation of Scarce Critical Care Resources During a Public Health Emergency – University of Pittsburg AND Commentary: A system to allocate scarce ventilators and ICU beds gains traction for not counting any group out – STAT (04/2020)
- Ethical guidance published for frontline staff dealing with pandemic – Royal College of Physicians (04/2020)
- Pandemic palliative care: beyond ventilators and saving lives – Canadian Medical Association Journal AND Commentary: A COVID-19 palliative care pandemic plan: An essential tool – Canadian Medical Association Journal (04/2020)
Videos:
Selected Articles:
- NEW – Editorial: Ethical road map through the covid-19 pandemic – The BMJ (05/2020)
- An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US – JAMA (05/2020)
- Ethics of reallocating ventilators in the covid-19 pandemic – The BMJ (05/2020)
- Allocating Scarce Resources and Triaging Patients during the COVID-19 Pandemic – Journal of the American College of Cardiology AND Commentary: COVID-19 Triage, Allocation Decisions Must Be Guided by Ethical Principles and Values – American College of Cardiology (05/2020)
- Privileges and Immunity Certification During the COVID-19 Pandemic – JAMA AND Related article: The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”) – JAMA
- CPR in the Covid-19 Era — An Ethical Framework – New England Journal of Medicine (05/2020)
- Ethics guidelines on COVID-19 triage—an emerging international consensus – Critical Care (05/2020)
- Ethics of controlled human infection to study COVID-19 – Science (05/2020)
- The Equitable Distribution of COVID-19 Therapeutics and Vaccines – JAMA (05/2020)
- Critical Conversations: Say This, Not That – CHEST (05/2020)
- Sure, The Velociraptors Are Still on The Loose, But That’s No Reason Not to Reopen Jurassic Park – McSweeney’s (05/2020)
- Universal Do-Not-Resuscitate Orders, Social Worth, and Life-Years: Opposing Discriminatory Approaches to the Allocation of Resources During the COVID-19 Pandemic and Other Health System Catastrophes – Annals of Internal Medicine (04/2020)
- Ventilator Triage Policies During the COVID-19 Pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors – Annals of Internal Medicine (04/2020)
- COVID-19 Ethics and Research – Mayo Clinic Proceedings (04/2020)
- Is it wrong to prioritise younger patients with covid-19? – The BMJ AND Commentary: Should age be a prioritizing factor in deciding who gets treated for COVID-19? – News Medical (04/2020)
- Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic – Journal of the American College of Surgeons (04/2020)
- Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic – Journal of the American College of Surgeons (04/2020)
- If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future – Nature Medicine (via @EricTopol see Tweet) (04/2020)
- Editorial: Cardiopulmonary Resuscitation after Hospital Admission with Covid-19 – The BMJ (04/2020)
- COVID-19 and experiences of moral injury in front-line key workers – Occupational Medicine (04/2020)
- Should we give priority care to healthcare workers in the covid-19 pandemic? – The BMJ Opinion (04/2020)
- Ethical considerations in the allocation of critical care resources when capacity is overwhelmed – Canadian Journal of Emergency Medicine (03/2020)
- The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19) – JAMA (03/2020)
- The Toughest Triage — Allocating Ventilators in a Pandemic – New England Journal of Medicine (03/2020)
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19 – New England Journal of Medicine AND Commentary: Life, or death? Experts guide pandemic medical equipment decisions – CIDRAP (03/2020)
News & Perspectives:
- Restarting America Means People Will Die. So When Do We Do It? – The New York Times (04/2020)
- Who gets a ventilator? New gut-wrenching state guidelines issued on rationing equipment – Boston Globe (04/2020)
- Doctors Need Room to Make the Wrenching Decisions They Face – The New York Times (04/2020)
- If it comes to rationing, I shouldn’t have to be the one deciding who should live and who should die – STAT (04/2020)
- Patient Has Virus and Serious Cancer. Should Doctors Withhold Ventilator? – The New York Times (04/2020)
- COVID Ethics: Should clinicians see patients without appropriate PPE? – First10EM (03/2020)
- Who Should Be Saved First? Experts Offer Ethical Guidance – The New York Times (03/2020)
- ICU doctors now face the toughest decisions they will ever have to make – The Guardian (03/2020)
- ‘Is Ordering Takeout Unethical?’ A Medical Ethicist Answers Some of the Most Common Moral Questions Around Coronavirus – TIME
- What if Two COVID-19 Victims Need Ventilators and Just One Is Available? – Scientific American
COVID-19 Radiology: This page will be updated as often as necessary and will be fixed the right column in our homepage.
Fri March 20 – 10 Stories of The Day!
20 Mar, 2020 | 11:12h | UTC
Commentary: CVD in the Setting of COVID-19: Considerations to Prepare Patients, Providers, Health Systems – American College of Cardiology (free)
3 – Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)
4 – COVID-19 Prioritization of Diagnostic Testing – Infectious Diseases Society of America (free PDF)
Summary: IDSA Statement On COVID-19 Testing Recommendations – Infectious Diseases Society of America (free)
5 – New Preliminary Studies with Hydroxychloroquine:
New Clinical Trial: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial – International Journal of Antimicrobial Agents (free PDF)
This was an open-label study with only 42 patients without patient-relevant endpoints. The 6 patients that received Hydroxychloroquine + Azithromycin achieved more efficient virus elimination than control patients.
New in Vitro Study: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Cell Discovery (free)
Related Articles: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – Clinical Infectious Diseases (free PDF) AND New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? – International Journal of Antimicrobial Agents (free) AND A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 – Journal of Critical Care (free) AND Of chloroquine and COVID-19 – Antiviral Research (free)
6 – Management of Kidney Stones in 2020 – JAMA (free for a limited period)
Related Guidelines: Renal and ureteric stones: assessment and management – National Institute for Health and Care Excellence (free) AND Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians (free) AND Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement – Journal of Nephrology (free) AND Medical Management of Kidney Stones: AUA Guideline (free) AND Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I (free) AND Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II (free) AND The Urological Association of Asia clinical guideline for urinary stone disease – International Journal of Urology (free)
Commentary: FDA advises stopping SGLT2 inhibitor treatment prior to surgery – The Hospitalist (free)
“- Canagliflozin, dapagliflozin, and empagliflozin should each be discontinued at least three days before scheduled surgery.
– Ertugliflozin should be discontinued at least four days before scheduled surgery.
– Blood glucose levels should be carefully monitored after discontinuation of the SGLT2 inhibitor and appropriately managed before surgery.”
Editorial: Suicide and the media: reporting could cost lives (free)
Commentaries: Responsible communication on suicide in the media is essential if we want to be serious about tackling the stigma surrounding suicide – The BMJ Opinion (free) AND Suicide and the media: reporting could cost lives – University of Bristol (free) AND Media reports of celebrity suicide linked to increased suicide rates – BMJ (free)
10 – Coronavirus Disease (COVID-19) Updates / 20 March 2020 Edition
20 March 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
CEBM Estimates Infection Rate Fatality (IFR) of COVID-19 at 0,20%
23 Mar, 2020 | 01:16h | UTCGlobal Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)
Review: Anti-arrhythmic Properties of Non-antiarrhythmic Medications
24 Mar, 2020 | 11:12h | UTCAnti-arrhythmic properties of non-antiarrhythmic medications – Pharmacological Research (free)
[Preprint] Randomized Trial: Favipiravir vs. Arbidol for COVID-19
23 Mar, 2020 | 01:18h | UTCFavipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial – medRxiv
Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19
23 Mar, 2020 | 01:34h | UTCRelated Study: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report (free)
“Introduction of COVID-19 into a long-term residential care facility in Washington resulted in cases among 81 residents, 34 staff members, and 14 visitors; 23 persons died” (from CDC)
Obesity Treatment Among Adolescents: A Review of Current Evidence and Future Directions
24 Mar, 2020 | 11:04h | UTCObesity Treatment Among Adolescents: A Review of Current Evidence and Future Directions – JAMA Pediatrics (free for a limited period)
Loss of Smell and Taste Could be a Sign of COVID-19
23 Mar, 2020 | 01:11h | UTCPosition Statement: Loss of sense of smell as marker of COVID-19 infection – ENT-UK
See also: There’s An Unexpected Loss Of Smell And Taste In Coronavirus Patients – Forbes AND If you’ve lost your sense of smell or taste, you could be a ‘hidden carrier’ of the coronavirus – Business Insider
IDSA Statement: COVID-19 Prioritization of Diagnostic Testing
20 Mar, 2020 | 11:01h | UTCCOVID-19 Prioritization of Diagnostic Testing – Infectious Diseases Society of America (free PDF)
Summary: IDSA Statement On COVID-19 Testing Recommendations – Infectious Diseases Society of America (free)
Editorial by John P.A. Ioannidis: COVID-19: The Harms of Exaggerated Information and Non‐evidence‐based Measures
23 Mar, 2020 | 01:08h | UTCRelated Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT (free)
Rebuttal 1: We know enough now to act decisively against Covid-19. Social distancing is a good place to start – STAT (free)
Rebuttal 2: A Rebuttal to “A Fiasco in the Making?” – Hilda Bastian (Free)
New Preliminary Studies with Hydroxychloroquine:
20 Mar, 2020 | 10:57h | UTCThis was an open-label study with only 42 patients without patient-relevant endpoints. The 6 patients that received Hydroxychloroquine + Azithromycin achieved more efficient virus elimination than control patients.
New in Vitro Study: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Cell Discovery (free)
Related Articles: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – Clinical Infectious Diseases (free PDF) AND New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? – International Journal of Antimicrobial Agents (free) AND A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 – Journal of Critical Care (free) AND Of chloroquine and COVID-19 – Antiviral Research (free)
[Abstract Only] Study: Selumetinib in Children with Inoperable Plexiform Neurofibromas
23 Mar, 2020 | 00:49h | UTCSelumetinib in Children with Inoperable Plexiform Neurofibromas – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1 – NIH News Releases (free)
Treatment of Patients with Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
23 Mar, 2020 | 00:50h | UTCCommentary: ASCO Releases Resource-Stratified Guideline on the Treatment of Late-Stage Colorectal Cancer – ASCO Daily News (free)
Consensus Guideline: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus Aureus Infections
20 Mar, 2020 | 11:07h | UTC
Meta-Analysis: The Risk of Tuberculosis in Children After Close Exposure
23 Mar, 2020 | 00:52h | UTCCommentary: Incidence of Tuberculosis High in Children Exposed to the Disease – Drugs.com (free)
One-year Results of a Factorial Randomized Trial of Aspirin vs. Placebo and Clonidine vs. Placebo in Patients Having Noncardiac Surgery
23 Mar, 2020 | 00:53h | UTC
CDC Guideline: Strategies for Optimizing the Supply of Facemasks
20 Mar, 2020 | 11:03h | UTCStrategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)
Special Article Series: COVID-19 Response and Perioperative Implications
23 Mar, 2020 | 00:57h | UTCHomepage: Special Article Series: COVID-19 Response and Perioperative Implications – Anesthesiology (free articles)
- Novel Coronavirus 2019 and Anesthesiology
- Preventing Infection of Patients and Healthcare Workers Should Be the New Normal in the Era of Novel Coronavirus Epidemics
- Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the joint task force of the Chinese Society of Anesthesiology and Chinese Association of Anesthesiologists
- Intubation and Ventilation Amid COVID-19 Outbreak
- Response of Chinese anesthesiologists to the COVID-19 outbreak
- Establishing and Managing a Temporary Coronavirus Disease 2019 Specialty Hospital in Wuhan, China
- COVID-19: Perioperative Implications
See also: COVID-19: Updates for Anesthesiologists
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic
20 Mar, 2020 | 11:05h | UTCCommentary: CVD in the Setting of COVID-19: Considerations to Prepare Patients, Providers, Health Systems – American College of Cardiology (free)